Alix Ventures

Alix Ventures is a venture capital firm dedicated to supporting early-stage life science startups, particularly those driving advancements in human health through the innovative fusion of technology and biology, often referred to as "TechBio." Founded by a team of experienced life science entrepreneurs, Alix Ventures aims to partner with founders who possess unique insights and the ambition to tackle some of the most pressing challenges in healthcare. The firm focuses on companies that are engineering biology to create transformative solutions, with a portfolio that includes startups like Xilis, Elegen, and Endpoint Health. These companies are at the forefront of developing technologies that enable precision medicine, advanced DNA writing, and immunology. Alix Ventures operates primarily out of San Francisco and Boston, but they also have a presence in other U.S. cities. They are known for their strong support network, providing not just capital but also valuable connections to industry experts, follow-on VCs, and key opinion leaders in pharma and healthcare. The firm’s advisory board comprises PhD-level bioengineers and industry veterans, ensuring deep technical diligence across a broad spectrum of life science sub-domains. With a strong commitment to driving patient impact, Alix Ventures continues to support breakthrough innovations that push the boundaries of what's possible in life sciences.